1. Home
  2. FULC vs JAKK Comparison

FULC vs JAKK Comparison

Compare FULC & JAKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

SELL

Current Price

$3.67

Market Cap

285.4M

Sector

Health Care

ML Signal

SELL

Logo JAKKS Pacific Inc.

JAKK

JAKKS Pacific Inc.

SELL

Current Price

$28.58

Market Cap

323.1M

ML Signal

SELL

Company Overview

Basic Information
Metric
FULC
JAKK
Founded
2015
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
285.4M
323.1M
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
FULC
JAKK
Price
$3.67
$28.58
Analyst Decision
Hold
Buy
Analyst Count
5
2
Target Price
$3.67
★ $28.50
AVG Volume (30 Days)
★ 1.4M
83.6K
Earning Date
10-28-2026
10-22-2026
Dividend Yield
N/A
★ 3.44%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.13
Revenue
N/A
★ $331,249,000.00
Revenue This Year
N/A
$5.09
Revenue Next Year
N/A
$8.59
P/E Ratio
★ N/A
$223.38
Revenue Growth
★ N/A
N/A
52 Week Low
$2.83
$14.87
52 Week High
$15.74
$29.06

Technical Indicators

Market Signals
Indicator
FULC
JAKK
Relative Strength Index (RSI) 39.62 67.54
Support Level $3.62 $21.34
Resistance Level $3.91 N/A
Average True Range (ATR) 0.06 0.96
MACD -0.00 0.20
Stochastic Oscillator 11.11 81.73

Price Performance

Historical Comparison
FULC
JAKK

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

About JAKK JAKKS Pacific Inc.

Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells, and distributes toys and related kid-targeted consumer products, including kids' indoor and outdoor furniture, costumes, and various product lines in the sporting goods and home furnishings space. Its product offerings include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: Toys/Consumer Products and Costumes. It generates the majority of its revenue from the Toys/Consumer Products segment.

Share on Social Networks: